NASDAQ:PBLA

Panbela Therapeutics Stock Insider Trading

etoro logo Buy PBLA
*Your capital is at risk
$0.0010
+0 (+0%)
At Close: Jun 02, 2026

Panbela Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 18.76M and sold 162.58K PBLA shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 18.76M shares
Sell 162.58K shares
92% Buy Activity
Moderate Negative Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Nov 15, 2024
Buy
8% Senior Convertible Note due 2025
P-Purchase
Nant Capital, Llc
10 Percent Owner
10% Owner 0
Value: $0
Nov 15, 2024
Buy
8% Senior Convertible Note due 2025
P-Purchase
Nant Capital, Llc
10 Percent Owner
10% Owner 0
Value: $0
Oct 22, 2024
Buy
8% Senior Convertible Tranche A Note due 2025
Nant Capital, Llc
10 Percent Owner
10% Owner 7 702 702
Value: $2.85M
Oct 22, 2024
Buy
8% Senior Convertible Tranche A Note due 2025
Nant Capital, Llc
10 Percent Owner
10% Owner 7 702 702
Value: $2.85M
Oct 01, 2024
Buy
Stock Option (right to buy)
A-Award
Horvath Susan
V.p. Of Finance & CFO
C-Suite Officer 25 480
Value: $10K
Oct 01, 2024
Buy
Stock Option (right to buy)
A-Award
Simpson Jennifer K.
President And CEO
CEO / President 72 800
Value: $28.3K
Oct 01, 2024
Buy
Stock Option (right to buy)
A-Award
Horvath Susan
V.p. Of Finance & CFO
C-Suite Officer 25 480
Value: $10K
Oct 01, 2024
Buy
Stock Option (right to buy)
A-Award
Simpson Jennifer K.
President And CEO
CEO / President 72 800
Value: $28.3K
Nov 08, 2023
Sell
Common Stock
S-Sale
Goldman Sachs Group Inc
10 Percent Owner
10% Owner 72 874
Value: $51.7K
Nov 08, 2023
Sell
Common Stock
S-Sale
Goldman Sachs Group Inc
10 Percent Owner
10% Owner 72 874
Value: $51.7K
Nov 07, 2023
Buy
Common Stock
Goldman Sachs Group Inc
10 Percent Owner
10% Owner 0
Value: $0
Nov 07, 2023
Buy
Common Stock
Goldman Sachs Group Inc
10 Percent Owner
10% Owner 0
Value: $0
Sep 12, 2023
Sell
Common Stock
G-Gift
Jacob Jeffrey E.
Director
Director 275
Value: $0
Sep 12, 2023
Sell
Common Stock
G-Gift
Jacob Jeffrey E.
Director
Director 275
Value: $0
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Simpson Jennifer K.
President And CEO
CEO / President 99 383
Value: $49.7K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Horvath Susan
V.p. Of Finance & CFO
C-Suite Officer 34 369
Value: $17.2K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Cullen Michael T.
Director 8 333
Value: $4K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Donovan Daniel
Director
Director 8 333
Value: $4K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Fratamico Arthur
Director
Director 8 333
Value: $4K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Jacob Jeffrey E.
Director
Director 8 333
Value: $4K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Mathiesen Jeffrey S
Director
Director 8 333
Value: $4K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Schemel Donald Robert
Director 8 333
Value: $4K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Simpson Jennifer K.
President And CEO
CEO / President 99 383
Value: $49.7K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Horvath Susan
V.p. Of Finance & CFO
C-Suite Officer 34 369
Value: $17.2K
Mar 27, 2023
Buy
Stock Option (right to buy)
A-Award
Cullen Michael T.
Director 8 333
Value: $4K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT PANBELA THERAPEUTICS INC.
Panbela Therapeutics
Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pancreatitis and pancreatic cancer, as well as neoadjuvant pancreatic cancer, colorectal cancer, ovarian cancer, and other agents in other cancer indications. Its lead product candidate is SBP-101, ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE